Preferred Label : Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1;
Symbol : MDDGC1;
CISMeF acronym : LGMD2K; MDDGC1; LGMDR11;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Muscular dystrophy, limb-girdle, type 2k; LGMD2K; Muscular dystrophy, limb-girdle, autosomal recessive 11; LGMDR11;
Description : Limb-girdle muscular dystrophies resulting from defective glycosylation of alpha-dystroglycan
(DAG1; 128230) represent the mildest end of the phenotypic spectrum of muscular dystrophies
collectively known as dystroglycanopathies. The limb-girdle phenotype is characterized
by onset of muscular weakness apparent after ambulation is achieved; mental retardation
and mild brain anomalies are variable (Balci et al., 2005; review by Godfrey et al.,
2007). The most severe end of the phenotypic spectrum of dystroglycanopathies is represented
by congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type
A; see;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the protein O-mannosyltransferase-1 gene (POMT1, 607423.0005);
Laboratory abnormalities : Increased serum creatine kinase;
Prefixed ID : #609308;
Origin ID : 609308;
UMLS CUI : C1836373;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)